Should C-Reactive Protein Be a Target of Therapy?

May 2011
Diabetes Care;May2011 Supplement 2, Vol. 34, pS155
Academic Journal
The article determines whether high-sensitivity C-reactive protein (hs-CRP) should be a target for therapy in the prevention of cardiovascular (CV) disease and other implications related to hs-CRP. Traditionally, hs-CRP was considered an indicator of systemic inflammation. However, it is considered as a potential marker of increased atherosclerotic CV disease and also a possible therapeutic target for the prevention of atherosclerotic CV disease. The findings of one trial has suggested a significant role for CRP as a therapy in preventing CV disease.


Related Articles

  • The Level of hs-CRP in Coronary Artery Ectasia and Its Response to Statin and Angiotensin-Converting Enzyme Inhibitor Treatment. Ozbay, Yilmaz; Akbulut, Mehmet; Balin, Mehmet; Kayancicek, Hidayet; Baydas, Adil; Korkmaz, Hasan // Mediators of Inflammation;2007, Vol. 2007 Issue 1, Special section p1 

    Background/Aim. Coronary artery ectasia (CAE) was thought of as a variant of atherosclerosis. C-reactive protein (CRP) which is among the most sensitive markers of systemic inflammation, and elevation of systemic and local levels of this inflammatory marker which has been associated with an...

  • It's still the one. Reichert, Ronald G. // Alive: Canada's Natural Health & Wellness Magazine;May2005, Issue 271, p76 

    Focuses on the health benefits of vitamin E in reducing cardiovascular disease. Role of vitamin E in atherosclerosis; Link of C-reactive protein to increased risk of heart disease; Symptoms of advanced heart problems.

  • Update on C-reactive protein as a risk marker in cardiovascular disease. Koenig, Wolfgang // Kidney International Supplement;May2003, Issue 84, p58 

    Update on C-reactive protein as a risk marker in cardiovascular disease. Atherosclerosis is characterized by a nonspecific local inflammatory process, which is accompanied by a systemic response. A number of prospective studies have convincingly demonstrated a strong and independent association...

  • Lipid Lowering Agents, Inflammation and Atherosclerosis. Broncel, Marlena; Koziróg, Marzena; Chojnowska-Jezierska, Julita // Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry;Sep2008, Vol. 7 Issue 3, p206 

    Atherosclerosis has been recognized as an inflammatory disease. The innate and adaptive immunity mechanisms are involved in atherogenesis. Low-grade inflammation is associated with innate immunity activation. The CRP has been proposed as the best indicator of low-grade inflammation and a...

  • Molecule of the moment. Healy, Bernadine // U.S. News & World Report;11/25/2002, Vol. 133 Issue 20, p65 

    Scientists who study atherosclerosis, the disease that clogs your arteries with fat and triggers heart attacks and strokes, have recently rediscovered an age-old agent that rises like a fever when the body is fighting off injury or infection. It's prudent to put C-reactive protein (CRP) in its...

  • Levels of acute phase proteins remain stable after ischemic stroke. Elkind, Mitchell S. V.; Coates, Kristen; Tai, Wanling; Paik, Myunghee C.; Boden-Albala, Bernadette; Sacco, Ralph L. // BMC Neurology;2006, Vol. 6, p37 

    Background: Inflammation and inflammatory biomarkers play an important role in atherosclerosis and cardiovascular disease. Little information is available, however, on time course of serum markers of inflammation after stroke. Methods: First ischemic stroke patients ≥40 years old had...

  • Physical Activity and High-Sensitivity C-Reactive Protein. Plaisance, Eric P.; Grandjean, Peter W. // Sports Medicine;2006, Vol. 36 Issue 5, p443 

    Cardiovascular disease (CVD) remains one of the leading causes of death and disability in developed countries around the world despite the documented success of lifestyle and pharmacological interventions. This illustrates the multifactorial nature of atherosclerosis and the use of novel...

  • Pentraxin-3 as a Marker of Advanced Atherosclerosis Results from the Bruneck, ARMY and ARFY Studies. Knoflach, Michael; Kiechl, Stefan; Mantovani, Alberto; Cuccovillo, Ivan; Bottazzi, Barbara; Qingbo Xu; Qingzhong Xiao; Arno Gasperi; Mayr, Agnes; Kehrer, Marlene; Willeit, Johann; Wick, Georg // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Objective: Pentraxins like C-reactive protein are key components of the innate immune system. Recently, pentraxin-3 (PTX3) has been proposed to be a specific marker of vascular inflammation, yet its association with atherosclerosis is still unclear. Methods and Results: PTX3 serum levels were...

  • C-Reactive Protein and Risk of Breast Cancer. Zhang, Shumin M.; Lin, Jennifer; Cook, Nancy R.; I-Min Lee; Manson, Joann E.; Buring, Julie E.; Ridker, Paul M. // JNCI: Journal of the National Cancer Institute;6/6/2007, Vol. 99 Issue 11, p890 

    Chronic inflammation is hypothesized to be associated with breast cancer development. However, data evaluating the association between C-reactive protein (CRP), a marker of systemic inflammation, and breast cancer risk are sparse. In the Women's Health Study, 27919 apparently healthy women aged...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics